Market Cap 565.45M
Revenue (ttm) 3.55M
Net Income (ttm) -187.35M
EPS (ttm) N/A
PE Ratio 11.55
Forward PE N/A
Profit Margin -5,277.47%
Debt to Equity Ratio 0.00
Volume 529,900
Avg Vol 948,456
Day's Range N/A - N/A
Shares Out 30.47M
Stochastic %K 27%
Beta 0.89
Analysts Sell
Price Target $23.50

Company Profile

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. The company's lead product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in pat...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 314 6297
Address:
1050 Waltham Street, Suite 302, Lexington, United States
MacGruber99
MacGruber99 Jan. 9 at 3:19 AM
$KROS tutes be loading up and unloading all the time. float is so small that these events will move the needle.
0 · Reply
sprmn
sprmn Jan. 8 at 9:55 AM
$KROS Max pain price is $20. Buy now and sell at any price beyond $20 if you are holding this short term.
0 · Reply
TheBehavioralTrader
TheBehavioralTrader Jan. 7 at 4:12 PM
$KROS Arbitrage retracement to the company buyback Point good entry area here in my opinion with the correct stop in Target around 21 plus... StockreversalsPremium.com
1 · Reply
okiejames
okiejames Jan. 6 at 4:36 PM
$KROS anyone have a clue whats going on here?
0 · Reply
amessagefromtheodd
amessagefromtheodd Jan. 1 at 9:04 AM
$CADL $IOVA $KROS $SLS $VXRT Happy New Year 🎊 🎈🎆 I have not forsaken you…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 31 at 6:45 PM
$KROS RSI: 35.34, MACD: 0.6948 Vol: 0.86, MA20: 20.92, MA50: 18.18 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
sprmn
sprmn Dec. 26 at 1:19 PM
$KROS wah $18.87, who is the lucky one?
0 · Reply
amessagefromtheodd
amessagefromtheodd Dec. 24 at 8:30 PM
$SLS I will tell you what $IOVA we must $KROS look after $CADL our own $VXRT The Saga Continues 2026
0 · Reply
sprmn
sprmn Dec. 24 at 12:37 PM
$KROS $KURA $TNXP $XBI where is the crying bear 🐻?
0 · Reply
TheHubSpotter
TheHubSpotter Dec. 24 at 12:15 PM
$KROS Expectations are now anchored to how progress validates the underlying thesis beyond narrative appeal. Long-term optimism depends on disciplined follow-through.
0 · Reply
Latest News on KROS
Keros Therapeutics Announces Final Results of Tender Offer

Nov 20, 2025, 4:01 PM EST - 7 weeks ago

Keros Therapeutics Announces Final Results of Tender Offer


Keros Therapeutics Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 4:01 PM EST - 2 months ago

Keros Therapeutics Reports Third Quarter 2025 Financial Results


Keros Reinforces Commitment to Maximizing Stockholder Value

May 8, 2025, 5:31 PM EDT - 8 months ago

Keros Reinforces Commitment to Maximizing Stockholder Value


Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump

Apr 10, 2025, 12:12 PM EDT - 9 months ago

Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump


Keros Therapeutics adopts 'poison pill' plan

Apr 10, 2025, 6:10 AM EDT - 9 months ago

Keros Therapeutics adopts 'poison pill' plan


Keros Therapeutics Announces Review of Strategic Alternatives

Apr 10, 2025, 6:00 AM EDT - 9 months ago

Keros Therapeutics Announces Review of Strategic Alternatives


MacGruber99
MacGruber99 Jan. 9 at 3:19 AM
$KROS tutes be loading up and unloading all the time. float is so small that these events will move the needle.
0 · Reply
sprmn
sprmn Jan. 8 at 9:55 AM
$KROS Max pain price is $20. Buy now and sell at any price beyond $20 if you are holding this short term.
0 · Reply
TheBehavioralTrader
TheBehavioralTrader Jan. 7 at 4:12 PM
$KROS Arbitrage retracement to the company buyback Point good entry area here in my opinion with the correct stop in Target around 21 plus... StockreversalsPremium.com
1 · Reply
okiejames
okiejames Jan. 6 at 4:36 PM
$KROS anyone have a clue whats going on here?
0 · Reply
amessagefromtheodd
amessagefromtheodd Jan. 1 at 9:04 AM
$CADL $IOVA $KROS $SLS $VXRT Happy New Year 🎊 🎈🎆 I have not forsaken you…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 31 at 6:45 PM
$KROS RSI: 35.34, MACD: 0.6948 Vol: 0.86, MA20: 20.92, MA50: 18.18 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
sprmn
sprmn Dec. 26 at 1:19 PM
$KROS wah $18.87, who is the lucky one?
0 · Reply
amessagefromtheodd
amessagefromtheodd Dec. 24 at 8:30 PM
$SLS I will tell you what $IOVA we must $KROS look after $CADL our own $VXRT The Saga Continues 2026
0 · Reply
sprmn
sprmn Dec. 24 at 12:37 PM
$KROS $KURA $TNXP $XBI where is the crying bear 🐻?
0 · Reply
TheHubSpotter
TheHubSpotter Dec. 24 at 12:15 PM
$KROS Expectations are now anchored to how progress validates the underlying thesis beyond narrative appeal. Long-term optimism depends on disciplined follow-through.
0 · Reply
amessagefromtheodd
amessagefromtheodd Dec. 24 at 2:59 AM
$KROS Interesting 🧐 🤔🤓
0 · Reply
sprmn
sprmn Dec. 23 at 11:40 AM
$KROS $KURA $TNXP $XBI where is the bear? 🐻
1 · Reply
sprmn
sprmn Dec. 23 at 1:37 AM
$XBI where is the bear? 🐻 $KURA $KROS $TNXP
0 · Reply
MacGruber99
MacGruber99 Dec. 22 at 7:29 PM
$KROS Zacks continues to comment on Keros with upgrade of status back to strong buy based on recent indicators and projected earnings trends. https://www.zacks.com/stock/news/2807563/keros-therapeutics-kros-upgraded-to-strong-buy-heres-why and https://www.zacks.com/stock/news/2807423/heres-why-keros-therapeutics-kros-could-be-great-choice-for-a-bottom-fisher
1 · Reply
MacGruber99
MacGruber99 Dec. 16 at 10:45 PM
$KROS Two more mentions from Zacks today on favorable P/B ratio and potential for reward vs risk in 2026 https://www.zacks.com/stock/news/2804697/zackscom-featured-highlights-include-stoneco-general-motors-enersys-deutsche-keros https://www.zacks.com/stock/news/2804883/5-high-risk-high-reward-biotech-breakthrough-stocks-to-watch-in-2026
0 · Reply
MacGruber99
MacGruber99 Dec. 16 at 12:48 AM
$KROS Zacks thinks there might be momentum here https://www.zacks.com/stock/news/2803928/what-makes-keros-therapeutics-inc-kros-a-strong-momentum-stock-buy-now
0 · Reply
sprmn
sprmn Dec. 10 at 11:37 PM
$KROS 🚀🚀🚀💪
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 10 at 1:11 AM
$KROS Share Price: $21.52 Contract Selected: Jun 18, 2026 $22.5 Calls Buy Zone: $2.55 – $3.15 Target Zone: $4.71 – $5.76 Potential Upside: 75% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
sprmn
sprmn Dec. 8 at 2:26 PM
1 · Reply
sprmn
sprmn Dec. 8 at 2:23 PM
$KROS Release the KRAKEN! Takeda….
0 · Reply
Uncle_Tom
Uncle_Tom Dec. 7 at 10:06 AM
$KROS not selling before gapclose
1 · Reply
Investor6
Investor6 Dec. 7 at 9:40 AM
$GTEC Current financial condition according to the 9 months results: Market Cap: $18.5 million Revenues (9-month): $66.8 million Gross Profit (9-month): $46.8 million Net Income (9-month): $8.4 million EPS (9-month): $0.41. All metrics would be much improved without the one-time expenses of Q2. The Enterprise Value is still Negative, by buying a share you own more cash minus liabilities than what you pay. For 2025: With EPS of Q3 at $0.33, the 2025 EPS could be at the range of $0.68 to $0.81 (Q4 EPS: from $0.25 to $0.40). The 2025 Revenues range could be from $84 million to $90 million. These numbers shape a P/E below 2 and a Market Cap to Sales below 0.25. Metrics like EV/Sales, EV/EBITDA are negative. For example, with GTEC stock at $2.00, EV/EBITDA is still below 1.5! With these numbers, GTEC is in the top-5 of undervalued stocks by almost any metric. In EV/EBITDA is ranked in No1 among $KROS $CISS $IMPP and $MYPS
2 · Reply